Abbott
FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests
The agency said the issue could be related to current mixing parameters of the PCR reaction mixture resulting in overflow in wells of the reagent tray.
Discarded But Now Needed
The New York Times writes that Abbott Laboratories workers discarded SARS-CoV-2 antigen test cards in June and July following decreased testing demand.
Abbott Q2 Diagnostics Revenues Rise 63 Percent on COVID-19 Testing Demand
The firm said that excluding COVID-19 testing sales, its worldwide diagnostics sales increased 42.5 percent on a reported basis in the second quarter.
Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue
The firm's CEO said that despite the decline, its base business is returning to normal and has "strong momentum."
Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing
The firm's growth was driven largely by demand for its rapid and laboratory-based COVID-19 tests, which totaled $2.2 billion in revenues for the quarter.
Nov 13, 2020
Abbott Enters $5B Credit Agreement
Oct 21, 2020